Reviews
Average rating: 5.00/5
Total Reviews: 1
JAFERD+
- February 28, 2025
Doxycycline is a reliable and cost-effective option for treating mild to moderate community-acquired pneumonia, offering broad-spectrum coverage against both typical and atypical pathogens. Its low resistance rates and twice-daily oral dosing make it a strong alternative to macrolides, especially in areas with high Streptococcus pneumoniae resistance.
Reply